The perioperative period in cancer surgery: A critical moment! Is there a role for regional anesthesia in preventing cancer recurrence?;La période périopératoire de chirurgie carcinologique : Un moment crucial ! L'anesthésie locorégionale prévient-elle la récidive des cancers ?

Annales Francaises d'Anesthesie et de Reanimation

Volumn 31, Issue 6, 2012, Pages 528-536

  Beloeil, H ^a   Nouette Gaulain, K ^b  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

Cancer; Carcinologic surgery; Locoregional anaesthesia; Metastasis; Natural killer cells; Recurrence

Indexed keywords

ANESTHESIOLOGICAL PROCEDURE; CANCER RECURRENCE; CANCER SURGERY; HUMAN; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; RECURRENCE RISK; REGIONAL ANESTHESIA; SHORT SURVEY;

ANESTHESIA, CONDUCTION; CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; PERIOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE;

EID: 84862876325     PISSN: 07507658     EISSN: 17696623     Source Type: Journal    
DOI: 10.1016/j.annfar.2012.01.037     Document Type: Short Survey

References (130)

1. Biki B., Mascha E., Moriarty D.C., Fitzpatrick J.M., Sessler D.I., Buggy D.J. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 2008, 109:180-187.
2. Christopherson R., James K.E., Tableman M., Marshall P., Johnson F.E. Long term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth Analg 2008, 107:325-332.
3. Exadaktylos A.K., Buggy D.J., Moriarty D.C., Mascha E., Sessler D.I. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis?. Anesthesiology 2006, 105:660-664.
4. Gottschalk A., Ford J.G., Regelin C.C., You J., Mascha E.J., Sessler D.I., et al. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology 2010, 113:27-34.
5. Sessler D.I. Long-term consequences of anesthetic management. Anesthesiology 2009, 111:1-4.
6. Jayr C., Muret J. Mécanismes de l'oncogénèse et principe des traitements antiacncéreux : implication pour l'anesthésiste. Le praticien en anesthésie réanimation 2010, 14:347-366.
7. Gottschalk A., Sharma S., Ford J., Durieux M.E., Tiouririne M. Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg 2010, 110:1636-1643.
8. Zetter B.R. Angiogenesis and tumor metastasis. Annu Rev Med 1998, 49:407-424.
9. Shakhar G., Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients?. Ann Surg Oncol 2003, 10:972-992.
10. Brittenden J., Heys S.D., Ross J., Eremin O. Natural killer cells and cancer. Cancer 1996, 77:1226-1243.
11. Forget P., De Kock M. Could anaesthesia, analgesia and sympathetic modulation affect neoplasic recurrence after surgery? A systematic review centred over the modulation of natural killer cells activity. Ann Fr Anesth Reanim 2009, 28:751-768.
12. Takeuchi H., Maehara Y., Tokunaga E., Koga T., Kakeji Y., Sugimachi K. Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis. Am J Gastroenterol 2001, 96:574-578.
13. Liljefors M., Nilsson B., Hjelm Skog A.L., Ragnhammar P., Mellstedt H., Frodin J.E. Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A. Int J Cancer 2003, 105:717-723.
14. Moloney F.J., Comber H., O'Lorcain P., O'Kelly P., Conlon P.J., Murphy G.M. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006, 154:498-504.
15. Demicheli R., Retsky M.W., Hrushesky W.J., Baum M., Gukas I.D. The effects of surgery on tumor growth: a century of investigations. Ann Oncol 2008, 19:1821-1828.
16. Goldfarb Y., Ben-Eliyahu S. Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. Breast Dis 2006, 26:99-114.
17. Snyder G.L., Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth 2010, 105:106-115.
18. Eschwege P., Dumas F., Blanchet P., Le Maire V., Benoit G., Jardin A., et al. Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet 1995, 346:1528-1530.
19. Wong I.H., Lau W.Y., Leung T., Yeo W., Johnson P.J. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin Cancer Res 1999, 5:4021-4027.
20. Yamaguchi K., Takagi Y., Aoki S., Futamura M., Saji S. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 2000, 232:58-65.
21. Abramovitch R., Marikovsky M., Meir G., Neeman M. Stimulation of tumour growth by wound-derived growth factors. Br J Cancer 1999, 79:1392-1398.
22. Ben-Eliyahu S., Page G.G., Yirmiya R., Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 1999, 80:880-888.
23. McCulloch P.G., MacIntyre A. Effects of surgery on the generation of lymphokine-activated killer cells in patients with breast cancer. Br J Surg 1993, 80:1005-1007.
24. Farrar M.W., Hall G.M. Neuroendocrine and inflammatory aspects of surgery: do they affect outcome?. Eur J Anaesthesiol 1998, 15:736-739.
25. Brand J.M., Kirchner H., Poppe C., Schmucker P. The effects of general anesthesia on human peripheral immune cell distribution and cytokine production. Clin Immunol Immunopathol 1997, 83:190-194.
26. Andersen B.L., Farrar W.B., Golden-Kreutz D., Kutz L.A., MacCallum R., Courtney M.E., et al. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst 1998, 90:30-36.
27. Page G.G., Blakely W.P., Ben-Eliyahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 2001, 90:191-199.
28. Melamed R., Bar-Yosef S., Shakhar G., Shakhar K., Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg 2003, 97:1331-1339.
29. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 2006;1:CD005033.
30. Beilin B., Shavit Y., Razumovsky J., Wolloch Y., Zeidel A., Bessler H. Effects of mild perioperative hypothermia on cellular immune responses. Anesthesiology 1998, 89:1133-1140.
31. Tsuchiya Y., Sawada S., Yoshioka I., Ohashi Y., Matsuo M., Harimaya Y., et al. Increased surgical stress promotes tumor metastasis. Surgery 2003, 133:547-555.
32. Vittimberga F.J., Foley D.P., Meyers W.C., Callery M.P. Laparoscopic surgery and the systemic immune response. Ann Surg 1998, 227:326-334.
33. Lacy A.M., Garcia-Valdecasas J.C., Delgado S., Castells A., Taura P., Pique J.M., et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 2002, 359:2224-2229.
34. Goldfarb M., Brower S., Schwaitzberg S.D. Minimally invasive surgery and cancer: controversies part 1. Surg Endosc 2010, 24:304-334.
35. Reiche E.M., Nunes S.O., Morimoto H.K. Stress, depression, the immune system, and cancer. Lancet Oncol 2004, 5:617-625.
36. Lutgendorf S.K., Cole S., Costanzo E., Bradley S., Coffin J., Jabbari S., et al. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res 2003, 9:4514-4521.
37. Thaker P.H., Han L.Y., Kamat A.A., Arevalo J.M., Takahashi R., Lu C., et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 2006, 12:939-944.
38. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun 2003, 17(Suppl. 1):S27-S36.
39. Woolf C.J., Costigan M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci USA 1999, 96:7723-7730.
40. Kundu J.K., Surh Y.J. Inflammation: gearing the journey to cancer. Mutat Res 2008, 659:15-30.
41. Jain S., Chakraborty G., Raja R., Kale S., Kundu G.C. Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Res 2008, 68:7750-7759.
42. Caro J.J., Salas M., Ward A., Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001, 91:2214-2221.
43. Weber R.S., Jabbour N., Martin R.C. Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol 2008, 15:34-45.
44. Ydy L.R., Slhessarenko N., de Aguilar-Nascimento J.E. Effect of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response after colorectal cancer resection. World J Surg 2007, 31:2044-2051.
45. Blajchman M.A., Bardossy L., Carmen R., Sastry A., Singal D.P. Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 1993, 81:1880-1882.
46. Busch O.R., Hop W.C., Hoynck van Papendrecht M.A., Marquet R.L., Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993, 328:1372-1376.
47. Heiss M.M., Mempel W., Delanoff C., Jauch K.W., Gabka C., Mempel M., et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994, 12:1859-1867.
48. Houbiers J.G., Brand A., van de Watering L.M., Hermans J., Verwey P.J., Bijnen A.B., et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994, 344:573-578.
49. Vamvakas E.C. WBC-containing allogeneic blood transfusion and mortality: a meta-analysis of randomized controlled trials. Transfusion 2003, 43:963-973.
50. Kurz A., Sessler D.I., Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 1996, 334:1209-1215.
51. Ben-Eliyahu S., Shakhar G., Rosenne E., Levinson Y., Beilin B. Hypothermia in barbiturate-anesthetized rats suppresses natural killer cell activity and compromises resistance to tumor metastasis: a role for adrenergic mechanisms. Anesthesiology 1999, 91:732-740.
52. Sacerdote P., Bianchi M., Gaspani L., Manfredi B., Maucione A., Terno G., et al. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg 2000, 90:1411-1414.
53. Shavit Y., Martin F.C., Yirmiya R., Ben-Eliyahu S., Terman G.W., Weiner H., et al. Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity. Brain Behav Immun 1987, 1:318-328.
54. Lewis J.W., Shavit Y., Terman G.W., Nelson L.R., Gale R.P., Liebeskind J.C. Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth. Peptides 1983, 4:635-638.
55. Page G.G., Ben-Eliyahu S. Indomethacin attenuates the immunosuppressive and tumor-promoting effects of surgery. J Pain 2002, 3:301-308.
56. Fried I.A. The influence of the anaesthetic on survival rates of breast cancer patients after surgery. Int J Cancer 1977, 20:213-218.
57. Shapiro J., Jersky J., Katzav S., Feldman M., Segal S. Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. J Clin Invest 1981, 68:678-685.
58. Kurosawa S., Kato M. Anesthetics, immune cells, and immune responses. J Anesth 2008, 22:263-277.
59. Katzav S., Shapiro J., Segal S., Feldman M. General anesthesia during excision of a mouse tumor accelerates postsurgical growth of metastases by suppression of natural killer cell activity. Isr J Med Sci 1986, 22:339-345.
60. Markovic S.N., Knight P.R., Murasko D.M. Inhibition of interferon stimulation of natural killer cell activity in mice anesthetized with halothane or isoflurane. Anesthesiology 1993, 78:700-706.
61. Forget P., Collet V., Lavand'homme P., De Kock M. Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages. Eur J Anaesthesiol 2010, 27:233-240.
62. Bentley M.W., Stas J.M., Johnson J.M., Viet B.C., Garrett N. Effects of preincisional ketamine treatment on natural killer cell activity and postoperative pain management after oral maxillofacial surgery. AANA J 2005, 73:427-436.
63. Mitsuhata H., Shimizu R., Yokoyama M.M. Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells. Int J Immunopharmacol 1995, 17:529-534.
64. Inada T., Kubo K., Kambara T., Shingu K. Propofol inhibits cyclooxygenase activity in human monocytic THP-1 cells. Can J Anaesth 2009, 56:222-229.
65. Inada T., Yamanouchi Y., Jomura S., Sakamoto S., Takahashi M., Kambara T., et al. Effect of propofol and isoflurane anaesthesia on the immune response to surgery. Anaesthesia 2004, 59:954-959.
66. Kushida A., Inada T., Shingu K. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol Immunotoxicol 2007, 29:477-486.
67. Mammoto T., Mukai M., Mammoto A., Yamanaka Y., Hayashi Y., Mashimo T., et al. Intravenous anesthetic, propofol inhibits invasion of cancer cells. Cancer Lett 2002, 184:165-170.
68. Fleischmann E., Marschalek C., Schlemitz K., Dalton J.E., Gruenberger T., Herbst F., et al. Nitrous oxide may not increase the risk of cancer recurrence after colorectal surgery: a follow-up of a randomized controlled trial. BMC Anesthesiol 2009, 9:1.
69. Wang J., Barke R.A., Charboneau R., Roy S. Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J Immunol 2005, 174:426-434.
70. Bonnet M.P., Beloeil H., Benhamou D., Mazoit J.X., Asehnoune K. The mu opioid receptor mediates morphine-induced tumor necrosis factor and interleukin-6 inhibition in toll-like receptor 2-stimulated monocytes. Anesth Analg 2008, 106:1142-1149. [Table of contents].
71. Fuggetta M.P., Di Francesco P., Falchetti R., Cottarelli A., Rossi L., Tricarico M., et al. Effect of morphine on cell-mediated immune responses of human lymphocytes against allogeneic malignant cells. J Exp Clin Cancer Res 2005, 24:255-263.
72. Gupta K., Kshirsagar S., Chang L., Schwartz R., Law P.Y., Yee D., et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 2002, 62:4491-4498.
73. Beilin B., Martin F.C., Shavit Y., Gale R.P., Liebeskind J.C. Suppression of natural killer cell activity by high-dose narcotic anesthesia in rats. Brain Behav Immun 1989, 3:129-137.
74. Shavit Y., Ben-Eliyahu S., Zeidel A., Beilin B. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation 2004, 11:255-260.
75. Chen Y.L., Law P.Y., Loh H.H. Inhibition of akt/protein kinase B signaling by naltrindole in small cell lung cancer cells. Cancer Res 2004, 64:8723-8730.
76. Page G.G., Ben-Eliyahu S., Yirmiya R., Liebeskind J.C. Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain 1993, 54:21-28.
77. Page G.G., McDonald J.S., Ben-Eliyahu S. Preoperative versus postoperative administration of morphine: impact on the neuroendocrine, behavioural, and metastatic-enhancing effects of surgery. Br J Anaesth 1998, 81:216-223.
78. Shavit Y., Lewis J.W., Terman G.W., Gale R.P., Liebeskind J.C. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 1984, 223:188-190.
79. Gaveriaux-Ruff C., Matthes H.W., Peluso J., Kieffer B.L. Abolition of morphine-immunosuppression in mice lacking the mu opioid receptor gene. Proc Natl Acad Sci USA 1998, 95:6326-6330.
80. Sasamura T., Nakamura S., Iida Y., Fujii H., Murata J., Saiki I., et al. Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation. Eur J Pharmacol 2002, 441:185-191.
81. Yeager M.P., Colacchio T.A., Yu C.T., Hildebrandt L., Howell A.L., Weiss J., et al. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology 1995, 83:500-508.
82. Beilin B., Shavit Y., Hart J., Mordashov B., Cohn S., Notti I., et al. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg 1996, 82:492-497.
83. Akural E.I., Salomaki T.E., Bloigu A.H., Ryhanen P., Tekay A.H., Alahuhta S.M., et al. The effects of pre-emptive epidural sufentanil on human immune function. Acta Anaesthesiol Scand 2004, 48:750-755.
84. Cronin A.J., Aucutt-Walter N.M., Budinetz T., Bonafide C.P., DiVittore N.A., Gordin V., et al. Low-dose remifentanil infusion does not impair natural killer cell function in healthy volunteers. Br J Anaesth 2003, 91:805-809.
85. Afsharimani B., Cabot P., Parat M.O. Morphine and tumor growth and metastasis. Cancer Metastasis Rev 2011, 30:225-238.
86. Farooqui M., Li Y., Rogers T., Poonawala T., Griffin R.J., Song C.W., et al. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer 2007, 97:1523-1531.
87. Sinicrope F.A., Gill S. Role of cyclooxygenase-2 in colorectal cancer. Cancer Metastasis Rev 2004, 23:63-75.
88. Roche-Nagle G., Connolly E.M., Eng M., Bouchier-Hayes D.J., Harmey J.H. Antimetastatic activity of a cyclooxygenase-2 inhibitor. Br J Cancer 2004, 91:359-365.
89. Kern M.A., Haugg A.M., Koch A.F., Schilling T., Breuhahn K., Walczak H., et al. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. Cancer Res 2006, 66:7059-7066.
90. Wei D., Wang L., He Y., Xiong H.Q., Abbruzzese J.L., Xie K. Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Res 2004, 64:2030-2038.
91. Jones M.K., Wang H., Peskar B.M., Levin E., Itani R.M., Sarfeh I.J., et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999, 5:1418-1423.
92. Forget P., Vandenhende J., Berliere M., Machiels J.P., Nussbaum B., Legrand C., et al. Do intraoperative analgesics influence breast cancer recurrence after mastectomy?. A retrospective analysis. Anesth Analg 2010, 110:1630-1635.
93. Poynter J.N., Gruber S.B., Higgins P.D., Almog R., Bonner J.D., Rennert H.S., et al. Statins and the risk of colorectal cancer. N Engl J Med 2005, 352:2184-2192.
94. Palm D., Lang K., Niggemann B., Drell TL, Masur K., Zaenker K.S., et al. The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int J Cancer 2006, 118:2744-2749.
95. Chalkiadaki G., Nikitovic D., Katonis P., Berdiaki A., Tsatsakis A., Kotsikogianni I., et al. Low molecular weight heparin inhibits melanoma cell adhesion and migration through a PKCa/JNK signaling pathway inducing actin cytoskeleton changes. Cancer Lett 2011, 312:235-244.
96. Beloeil H., Mazoit J.X. Effect of local anesthetics on the postoperative inflammatory response. Ann Fr Anesth Reanim 2009, 28:231-237.
97. Sakaguchi M., Kuroda Y., Hirose M. The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor. Anesth Analg 2006, 102:1103-1107.
98. Arai Y., Kondo T., Tanabe K., Zhao Q.L., Li F.J., Ogawa R., et al. Enhancement of hyperthermia-induced apoptosis by local anesthetics on human histiocytic lymphoma U937 cells. J Biol Chem 2002, 277:18986-18993.
99. Mammoto T., Higashiyama S., Mukai M., Mammoto A., Ayaki M., Mashimo T., et al. Infiltration anesthetic lidocaine inhibits cancer cell invasion by modulating ectodomain shedding of heparin-binding epidermal growth factor-like growth factor (HB-EGF). J Cell Physiol 2002, 192:351-358.
100. Blumenthal S., Borgeat A., Pasch T., Reyes L., Booy C., Lambert M., et al. Ropivacaine decreases inflammation in experimental endotoxin-induced lung injury. Anesthesiology 2006, 104:961-969.
101. Martinsson T. Ropivacaine inhibits serum-induced proliferation of colon adenocarcinoma cells in vitro. J Pharmacol Exp Ther 1999, 288:660-664.
102. Karniel M., Beitner R. Local anesthetics induce a decrease in the levels of glucose 1, 6-bisphosphate, fructose 1,6-bisphosphate, and ATP, and in the viability of melanoma cells. Mol Genet Metab 2000, 69:40-45.
103. Jose C., Bellance N., Hébert Chatelain E., Bernard G., Nouette-Gaulain K., et al. Antiproliferative activity of levobupivacaine and aminoimidazole carboxamide ribonucleotide on human cancer celles of variable bioenergetic profile. Mitochondrion 2012, 12:100-109.
104. Renzi P.M., Ginns L.C. Effect of lidocaine on natural killer activity: rapid inhibition of lysis. Immunopharmacol Immunotoxicol 1990, 12:417-437.
105. Renzi P.M., Ginns L.C. Natural killer activity is present in rat lung lavage and inhibited by lidocaine. Immunopharmacol Immunotoxicol 1990, 12:389-415.
106. Takagi S., Kitagawa S., Oshimi K., Takaku F., Miura Y. Effect of local anaesthetics on human natural killer cell activity. Clin Exp Immunol 1983, 53:477-481.
107. Krog J., Hokland M., Ahlburg P., Parner E., Tonnesen E. Lipid solubility- and concentration-dependent attenuation of in vitro natural killer cell cytotoxicity by local anesthetics. Acta Anaesthesiol Scand 2002, 46:875-881.
108. Yokoyama M., Itano Y., Mizobuchi S., Nakatsuka H., Kaku R., Takashima T., et al. The effects of epidural block on the distribution of lymphocyte subsets and natural killer cell activity in patients with and without pain. Anesth Analg 2001, 92:463-469.
109. Yardeni I.Z., Beilin B., Mayburd E., Levinson Y., Bessler H. The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg 2009, 109:1464-1469.
110. Wada H., Seki S., Takahashi T., Kawarabayashi N., Higuchi H., Habu Y., et al. Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance. Anesthesiology 2007, 106:499-506.
111. Bar-Yosef S., Melamed R., Page G.G., Shakhar G., Shakhar K., Ben-Eliyahu S. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 2001, 94:1066-1073.
112. Deruddre S., Combettes E., Estebe J.P., Duranteau J., Benhamou D., Beloeil H., et al. Effects of a bupivacaine nerve block on the axonal transport of Tumor Necrosis Factor-alpha (TNF-alpha) in a rat model of carrageenan-induced inflammation. Brain Behav Immun 2010, 24:652-659.
113. Munoz M., Rosso M., Casinello F., Covenas R. Paravertabral anesthesia: how substance P and NK-1 receptor could be involved in regional block and breast cancer recurrence. Breast Cancer Res Treat 2010, 122:601-603.
114. Koltun W.A., Bloomer M.M., Tilberg A.F., Seaton J.F., Ilahi O., Rung G., et al. Awake epidural anesthesia is associated with improved natural killer cell cytotoxicity and a reduced stress response. Am J Surg 1996, 171:68-72. [Discussion -3].
115. Tonnesen E., Wahlgreen C. Influence of extradural and general anaesthesia on natural killer cell activity and lymphocyte subpopulations in patients undergoing hysterectomy. Br J Anaesth 1988, 60:500-507.
116. Deegan C.A., Murray D., Doran P., Ecimovic P., Moriarty D.C., Buggy D.J. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br J Anaesth 2009, 103:685-690.
117. Beilin B., Shavit Y., Trabekin E., Mordashev B., Mayburd E., Zeidel A., et al. The effects of postoperative pain management on immune response to surgery. Anesth Analg 2003, 97:822-827.
118. Salo M., Nissila M. Cell-mediated and humoral immune responses to total hip replacement under spinal or general anaesthesia. Acta Anaesthesiol Scand 1990, 34:241-248.
119. Sessler D.I. Does regional analgesia reduce the risk of cancer recurrence? A hypothesis. Eur J Cancer Prev 2008, 17:269-272.
120. Bovill J.G. Surgery for cancer: does anesthesia matter?. Anesth Analg 2010, 110:1524-1526.
121. Sessler D.I., Ben-Eliyahu S., Mascha E.J., Parat M.O., Buggy D.J. Can regional analgesia reduce the risk of recurrence after breast cancer?. Methodology of a multicenter randomized trial. Contemp Clin Trials 2008, 29:517-526.
122. Schlagenhauff B., Ellwanger U., Breuninger H., Stroebel W., Rassner G., Garbe C. Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res 2000, 10:165-169.
123. Myles P.S., Peyton P., Silbert B., Hunt J., Rigg J.R., Sessler D.I. Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. BMJ 2011, 342:d1491.
124. Tsui B.C., Rashiq S., Schopflocher D., Murtha A., Broemling S., Pillay J., et al. Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can J Anaesth 2010, 57:107-112.
125. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000, 52:595-638.
126. Gupta A., Bjornsson A., Fredriksson M., Hallbook O., Eintrei C. Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in Central Sweden. Br J Anaesth 2011, 107:164-170.
127. Wuethrich P.Y., Hsu Schmitz S.F., Kessler T.M., Thalmann G.N., Studer U.E., Stueber F., et al. Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiology 2010, 113:570-576.
128. Ismail H., Ho K.M., Narayan K., Kondalsamy-Chennakesavan S. Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study. Br J Anaesth 2010, 105:145-149.
129. de Oliveira G.S., Ahmad S., Schink J.C., Singh D.K., Fitzgerald P.C., McCarthy R.J. Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Reg Anesth Pain Med 2011, 36:271-277.
130. Lin L., Liu C., Tan H., Ouyang H., Zhang Y., Zeng W. Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: a retrospective analysis. Br J Anaesth 2011, 106:814-822.